Diagnostic Center | December 15, 2022
Biocon initiates clinical study of Itolizumab for ulcerative colitis in India
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
As a result, Imago will become a subsidiary of Merck.
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
More women centric initiatives being the need of the hour for holistic development
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers
Subscribe To Our Newsletter & Stay Updated
